Anika Therapeutics Inc. · NASDAQ:ANIK
BlackRock, Inc. reported a 10.60% stake in Anika Therapeutics Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc. reported a 10.60% stake in Anika Therapeutics Inc., 1,557,882 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 10.60%
- Shares
- 1,557,882
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 10.60% | 1,557,882 |
Source
Related
- Anika Therapeutics Inc.
- BlackRock, Inc.
- Anika Therapeutics Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Form 4 · Fischetti Gary P · Aug 5, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Jul 17, 2026
- Form 4 · Fischetti Gary P · Jun 23, 2026
- Form 4 · Henneman John B III · Jun 23, 2026